Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

308.76 +2.13 (+0.69%)

Streaming Delayed Price Updated: 12:13 PM EDT, May 28, 2026 Add to My Watchlist

Price and Volume

Volume	45,744
Open	306.00
Bid (Size)	308.40 (80)
Ask (Size)	309.50 (200)
Prev. Close	306.63
Today's Range	299.28 - 309.07
52wk Range	123.03 - 319.48
Shares Outstanding	22,205,642
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why This Tech Fund Made a $5.8 Million Bet on an AI Chip Stock Up Nearly 200% Post-IPO ↗

May 14, 2026

Ambiq Micro designs ultra-low-power chips for wearables, IoT, and edge AI, targeting energy efficiency in connected devices.

Via The Motley Fool

This AI Semiconductor Stock Beat the S&P 500 by 9 Points. A Fund Just Exited Completely ↗

May 14, 2026

Ambarella delivers advanced semiconductor solutions for video, AI, and computer vision across automotive, security, and robotics markets.

Via The Motley Fool

Performance

YTD	+25.0%	+25.0%
1 Month	+13.2%	+13.2%
3 Month	+13.3%	+13.3%
6 Month	+41.2%	+41.2%
1 Year	+144.2%	+144.2%

More News

Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗

May 10, 2026

Via The Motley Fool

Krystal Biotech (NASDAQ:KRYS) Combines Perfect Trend Template with High-Growth Momentum ↗

May 09, 2026

Via Chartmill

Krystal Biotech (NASDAQ:KRYS) Surges After Q1 Beat as VYJUVEK Revenue Hits $116.4M ↗

May 04, 2026

Via Chartmill

Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗

May 10, 2026

Via The Motley Fool

Krystal (KRYS) Q1 2026 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Krystal (KRYS) Q1 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Krystal Biotech Inc (NASDAQ:KRYS) Reports Q4 2025 Earnings Beat and Key Pipeline Advancements ↗

February 17, 2026

Via Chartmill

Is Paymentus Stock a Buy After Palisades Investment Partners Increased Its Stake By $6 Million? ↗

May 01, 2026

Via The Motley Fool

Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million? ↗

May 01, 2026

Via The Motley Fool

Palisades Investment Partners Initiated a Position in SkyWater Technology Stock. What Does This Mean for Investors? ↗

May 01, 2026

Via The Motley Fool

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗

April 16, 2026

Via The Motley Fool

Is Vertex Pharmaceuticals' Empire in Trouble? ↗

April 16, 2026

Via The Motley Fool

Could This Under-the-Radar Healthcare Stock Set You Up for Life? ↗

April 07, 2026

Via The Motley Fool

Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services

March 23, 2026

From Palvella Therapeutics Inc.

Via GlobeNewswire

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Via The Motley Fool

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗

March 16, 2026

Via The Motley Fool

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗

February 22, 2026

Via The Motley Fool

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗

February 22, 2026

Via The Motley Fool

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗

February 22, 2026

Via The Motley Fool

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗

February 22, 2026

Via The Motley Fool

Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗

February 22, 2026

Via The Motley Fool

KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism ↗

February 17, 2026

Via Stocktwits

Krystal Biotech (KRYS) Q4 2025 Earnings Transcript ↗

February 17, 2026

Via The Motley Fool

Frequently Asked Questions

Is Krystal Biotech, Inc. - Common Stock publicly traded?

Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.

What exchange does Krystal Biotech, Inc. - Common Stock trade on?

Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?

The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market

What is the current price of Krystal Biotech, Inc. - Common Stock?

The current price of Krystal Biotech, Inc. - Common Stock is 308.76

When was Krystal Biotech, Inc. - Common Stock last traded?

The last trade of Krystal Biotech, Inc. - Common Stock was at 05/28/26 12:13 PM ET

What is the market capitalization of Krystal Biotech, Inc. - Common Stock?

The market capitalization of Krystal Biotech, Inc. - Common Stock is 6.86B

How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?

Krystal Biotech, Inc. - Common Stock has 7B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.